Artos
Authoring documents for life sciences in minutes, not months.
Based based in San Francisco, CA, USA, Artos works in b2b, founded in 2000.
Profile
Artos is an AI-based document-drafting platform that helps life sciences companies turn their data into critical documents in minutes. These submissions currently take months and are the final hurdle before life sciences companies are allowed to sell their product.
The company sits in the b2b segment, where it competes on its core product or service.
Its base of operations is San Francisco, CA, USA.
Its current recorded stage is Winter 2024.
The company reports a headcount in the 7 range.
Total disclosed funding stands at about $5K.
Directory analysis
Artos is a San Francisco‑based AI‑powered platform that enables life‑science companies to draft regulatory and other critical documents quickly, reducing the typical months‑long process to minutes. The service focuses on converting scientific data into formal submissions required for product approval and market entry. With a small team of seven employees, Artos has raised $500 k in funding as of Winter 2024.
Positioning: Artos operates in a niche B2B market, providing a specialized AI solution for regulatory documentation in the life‑sciences sector. Its early-stage positioning and limited funding suggest a focus on product development and customer acquisition rather than rapid scaling.
Note: Artos helps life‑science firms accelerate regulatory submissions through AI document drafting.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | B2B |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Founded | 2000 |
| Employees | 7 |
| Stage | Winter 2024 |
| Total funding | $500,000 |
Website: www.artosai.com
Browse related
Create a free account